article_metadata: Lily C Pham Lauryn Weller Claudia N Gann Karl Maria Schumacher Soetkin Vlassak Todd Swanson Kaitlin Highsmith Barbara J O'Brien Sebnem Nash Ashley Aaroe John F de Groot Nazanin K Majd
article_metadata: 10.1093/oncolo/oyae100
article_metadata: Oncologist
article_metadata: 2025 Jan 17;30(1):oyae100.
article_metadata: glioblastoma molecular alteration outcomes targeted therapy tepotinib
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38815166/
article_metadata: Brain Neoplasms / drug therapy Brain Neoplasms / genetics Brain Neoplasms / pathology Glioblastoma / drug therapy Glioblastoma / genetics Glioblastoma / pathology
article_metadata: Brain Neoplasms / drug therapy Brain Neoplasms / genetics Brain Neoplasms / pathology Glioblastoma / drug therapy Glioblastoma / genetics Glioblastoma / pathology Case Reports Epithelial-Mesenchymal Transition / drug effects Humans Male Middle Aged Piperidines Proto-Oncogene Proteins c-met / genetics Pyridazines Pyrimidines / pharmacology Pyrimidines / therapeutic use tepotinib Pyrimidines Proto-Oncogene Proteins c-met Piperidines Pyridazines
article_metadata: PMC11783278
article_metadata: 38815166
article_metadata: Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion
article_metadata: 2025